Maren Laughlin

Dr. Maren Laughlin


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2016 in Cell Metabolism
Verified
Journal Article
Closed access
KCKong Chen
Kong Chen
ACAaron M. Cypess
Aaron M. Cypess
MLMaren Laughlin
Maren Laughlin
CHCarol R. Haft
Carol R. Haft
HHHouchun Harry Hu
Houchun Harry Hu
RWRichard L. Wahl
Richard L. Wahl

1 September 2014 in Cell Metabolism
Verified
Journal Article
Closed access
ACAaron M. Cypess
Aaron M. Cypess
CHCarol R. Haft
Carol R. Haft
MLMaren Laughlin
Maren Laughlin
HHHouchun H. Hu
Houchun H. Hu

5 August 2014 in Nutrients
Verified
Journal Article
Open access
PDF file
MLMaren Laughlin
Maren Laughlin
Although there are many well-documented metabolic effects linked to the fructose component of a very high sugar diet, a healthy diet is also likely to contain appreciable fructose, even if confined to that found in fruits and vegetables. These normal levels of fructose are metabolized in specialized pathways that synergize with glucose at several metabolic steps. Glucose potentiates fructose absorption from the gut, while fructose catalyzes glucose uptake and storage in the liver. Fructose accelerates carbohydrate oxidation after a meal. In addition, emerging evidence suggests that fructose may also play a role in the secretion of insulin and GLP-1, and in the maturation of preadipocytes to increase fat storage capacity. Therefore, fructose undergoing its normal metabolism has the interesting property of potentiating the disposal of a dietary carbohydrate load through several routes.

1 May 2014 in Advances in Nutrition
Verified
Journal Article
Closed access
MLMaren Laughlin
Maren Laughlin
JBJohn P. Bantle
John P. Bantle
PHPeter Havel
Peter Havel
EPElizabeth Parks
Elizabeth Parks
DKDavid Klurfeld
David Klurfeld
PMPadma Maruvada
Padma Maruvada
Fructose and simple sugars are a substantial part of the western diet, and their influence on human health remains controversial. Clinical studies in fructose nutrition have proven very difficult to conduct and interpret. NIH and USDA sponsored a workshop on 13-14 November 2012, "Research Strategies for Fructose Metabolism," to identify important scientific questions and parameters to be considered while designing clinical studies. Research is needed to ascertain whether there is an obesogenic role for fructose-containing sugars via effects on eating behavior and energy balance and whether there is a dose threshold beyond which these sugars promote progression toward diabetes and liver and cardiovascular disease, especially in susceptible populations. Studies tend to fall into 2 categories, and design criteria for each are described. Mechanistic studies are meant to validate observations made in animals or to elucidate the pathways of fructose metabolism in humans. These highly controlled studies often compare the pure monosaccharides glucose and fructose. Other studies are focused on clinically significant disease outcomes or health behaviors attributable to amounts of fructose-containing sugars typically found in the American diet. These are designed to test hypotheses generated from short-term mechanistic or epidemiologic studies and provide data for health policy. Discussion brought out the opinion that, although many mechanistic questions concerning the metabolism of monosaccharide sugars in humans remain to be addressed experimentally in small highly controlled studies, health outcomes research meant to inform health policy should use large, long-term studies using combinations of sugars found in the typical American diet rather than pure fructose or glucose.

1 September 2012 in Mammalian Genome
Verified
Journal Article
Closed access
PDF file
MLMaren Laughlin
Maren Laughlin
KLK. C. Kent Lloyd
K. C. Kent Lloyd
GCGary W. Cline
Gary W. Cline
DWDavid H. Wasserman
David H. Wasserman

24 March 2021 in Obesity
Verified
Journal Article
Open access
PDF file
MLMaren Laughlin
Maren Laughlin
SOStavroula K. Osganian
Stavroula K. Osganian
SYSusan Z. Yanovski
Susan Z. Yanovski
CLChristopher J. Lynch
Christopher J. Lynch
Preventing regain of lost weight is the most difficult challenge in the treatment of obesity. The National Institute of Diabetes and Digestive and Kidney Diseases convened a workshop, “The Physiology of the Weight‐Reduced State,” on June 3 to 4, 2019, in order to explore the physiologic mechanisms of appetitive and metabolic adaptation that take place in the weight‐reduced state and counter an individual’s efforts to maintain reduced weight following weight loss.